Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MESEMS
NCT01730547Phase 2Completed
- Sponsor
- Karolinska Institutet
- Start
- Feb 2013
- Primary completion
- May 2019
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of autologous mesenchymal stem cells in multiple sclerosis (MS), sponsored by Karolinska Institutet. Started Feb 2013; status: completed.
02
Drugs
autologous mesenchymal stem cells
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT01730547.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01730547.